首页> 外文OA文献 >A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group

【2h】

A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group

机译：在患有复发或难治性实体肿瘤的儿童和青少年中的Cabozantib阶段研究，包括CNS肿瘤：试验Advl1211，来自儿童肿瘤组的报告

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Meredith K. Chuk; Brigitte C. Widemann; Charles G. Minard; Xiaowei Liu; AeRang Kim; Melanie Brooke Bernhardt; Rachel A. Kudgus; Joel M. Reid; Stephan D. Voss; Susan Blaney; Elizabeth Fox; Brenda J. Weigel;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group [J] . Chuk Meredith K., Widemann Brigitte C., Minard Charles G., Pediatric blood & cancer . 2018,第8期

机译：在患有复发或难治性实体肿瘤的儿童和青少年中的Cabozantib阶段研究，包括CNS肿瘤：试验Advl1211，来自儿童肿瘤组的报告
2. Phase 1/2 Trial to Assess the Activity of Entrectinib in Children and Adolescents with Recurrent or Refractory Solid Tumors Including Central Nervous System (CNS) Tumors [J] . Desai A. V., Gajjar A., Gauvain K., Pediatric blood & cancer . 2019,第S4期

机译：第1/2期试验评估儿童和青少年entectinib的活性，所述甾醇与复发性或难治性固体瘤，包括中枢神经系统（CNS）肿瘤
3. A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315) [J] . Geller James I, Fox Elizabeth, Turpin Brian K., Cancer: A Journal of the American Cancer Society . 2018,第23期

机译：AXITINIB，VEGF受体酪氨酸激酶抑制剂，儿童和青少年具有复发或难治性固体瘤的研究：儿童肿瘤学阶段1和试点联盟试验（ADVL1315）
4. Pre/peri- or postnatal medical history on the risk of brain tumors in children and adolescents: reports from CEFALO multicenter case-control study [C] . Xiaochen Shu, Maria Feychting, Martin Roeoesli, Annual conference of the International Society of Exposure Science . 2014

机译：儿童和青少年脑肿瘤风险的产前/产前或产后病史：CEFALO多中心病例对照研究的报告
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. A Phase 1 Study of Cabozantinib in Children and Adolescents with Recurrent or Refractory Solid Tumors Including CNS Tumors: Trial ADVL1211 A Report from the Children’s Oncology Group [O] . Meredith K. Chuk, Brigitte C. Widemann, Charles G. Minard, -1

机译：卡波替尼在患有复发性或难治性实体瘤（包括中枢神经系统肿瘤）的儿童和青少年中的一项1期研究：ADVL1211试验儿童肿瘤学小组的一份报告
7. A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot consortium trial (ADVL1315) [O] . James I. Geller, Elizabeth Fox, Brian K. Turpin, 2018

机译：具有复发或难治性固体瘤的儿童和青少年的Axitinib，VEGF受体酪氨酸激酶抑制剂：儿童肿瘤组阶段1和试验联盟试验（ADVL1315）

A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group

著录项

引文网络

相似文献

相关主题

期刊订阅